Revolutionary progress, like that of GLP-1 drugs, happens when many exceptional people work together, following a robust ...

Blackstone Life Sciences agreed to give Merck $700 million to support its development of an investigational cancer drug called sacituzumab tirumotecan in exchange for low-to-mid-single-digit royalties ...

The number of medications in development to treat obesity continues to grow, and the drugs can offer health benefits for ...

FDA announces major reforms to streamline biosimilar approvals, potentially saving Americans billions on prescription drug ...

The FDA today unveiled a plan to accelerate development of biosimilars in hopes of significantly reducing drug costs in the United States.The agency issued draft guidance that would simplify the study ...

Wholesale prices are in the gutter across much of Europe, forcing drug smugglers to try and manipulate the market. OCCRP ...

Jo Varshney, PhD, DVM, discusses how artificial intelligence–powered simulations speed drug approvals and reduce clinical ...

More than two weeks after President Donald Trump said he would halt “all payments” to Colombia, there has not been any ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to DPTX3186, an investigational therapy being ...

Malaria is a lethal parasitic infectious disease caused by Plasmodium protozoa. Despite significant advancements in ...

In this week’s edition of InnovationRx, we look Nvidia’s collaborations in life sciences and drug development, Cobot’s ...

Pregnancies do not weaken a woman's skeleton. Breastfeeding, however, can reduce bone density considerably. These are ...